← Eichor
Study identifier: NCT06615492 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Routine vs On-demand ECMO for Lung Transplantation

Condition: Respiratory Failure · Interstitial Lung Disease (ILD) · Pulmonary Fibrosis  ·  Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

PhaseNA
Planned participants218
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Lung transplantation is a complex procedure performed in patients with terminal lung disease. The transplant procedure stresses the patient's heart and lungs, which are already taxed by the underlying disease process. The heart-lung machine is occasionally used to support the patient and ensure adequate oxygen supply to other organs during the operation. It can be used routinely in all patients or selectively in patients who exhibit reduced oxygen supply to the remaining organs. This process, known as cardiopulmonary bypass (CPB), pumps blood out of the body to a heart-lung machine that removes carbon dioxide and returns oxygen-filled blood to the body. Although using the CPB increases the risk of bleeding, infection, and coagulation complications, it should still be considered in high-risk patients to compensate for more severe complications such as kidney failure and stroke caused by a lack of cardiopulmonary support. Extracorporeal membrane oxygenation (ECMO) is a recently developed CPB variation associated with fewer bleeding complications. It has recently replaced the traditional heart-lung machine as the preferred method of cardiopulmonary support during lung transplantation. Since ECMO is associated with fewer complications than standard CPB, many centers have increased their use of ECMO during lung transplantation. Some have even employed it routinely. However, there remains significant debate on how often it should be used. Therefore, the study's main objective is …

This description comes directly from the study's public registry record.

Talk to the study team

Basil Nasir, MD  ·  514-890-8000  ·  basilsnasir@gmail.com

Alex Moore, MD  ·  514-890-8000  ·  alex.moore@umontreal.ca

Always discuss trial participation with your own doctor first.

Locations (4)

Univeristy of Alberta & Alberta Health ServicesEdmonton, Alberta, CanadaNot Yet Recruiting
Vancouver General HospitalVancouver, British Columbia, CanadaNot Yet Recruiting
University Health Network / Toronto General HospiatlToronto, Ontario, CanadaNot Yet Recruiting
Centre Hospitalier de l'Universite de MontrealMontreal, Quebec, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06615492